Published in MPW, 23 Sep 2015
Nanoparticles inhaled, rather than injected, into the body are much more effective at boosting radiotherapy. That is the conclusion of a group of US scientists, who have performed calculations to gauge the difference between the two nanoparticle entry routes when treating lung cancer (Phys. Med. Biol. 60 7035).
Lung cancer has a particularly high mortality rate compared with other cancers, with five-year survival rates of only about 16%. It is often treated in a two-pronged attack of radiotherapy and chemoradiotherapy, but these can lead to severe side effects. […]
The rest of this article is available here.